Atyr Pharma Inc

NASDAQ:LIFE  
8.08
-0.02 (-0.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)224.54M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.52 Million
Adjusted EPS-$0.35
See more estimates
10-Day MA$8.25
50-Day MA$8.98
200-Day MA$5.79
See more pivots

Atyr Pharma Inc Stock, NASDAQ:LIFE

3545 John Hopkins Court, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.731.8389
Number of Employees: 43

Description

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. Its product pipeline include ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1;DARS-1(3). The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.